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The protein coded by a bleomycin-resistance g ne (b/e) cloned from producing actinomycetes was purified from a culture 
of a recombinant E.coli strain and its action on bleomycin was determined by in vitro assays. The protein binds reversibly 
in a one to one ratio to bleomycin which can no longer cleave DNA. The bleomycin resistance of cells harboring a ble 
gene could be accounted for by a sequestering effect of the bleomycin-binding protein. 
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1. INTRODUCTION 
Bleomycin and the related antibiotics, 
phleomycin and tallysomycin, are DNA-breaking 
compounds which kill both procaryotic and 
eucaryotic cells at low concentrations [1,2]. 
Although these antibiotics have never been used as 
antimicrobial agents, plasmid-mediated resistance 
to bleomycin is widely spread among clinically im- 
portant aminoglycoside-resistant Gram-negative 
[3] and Gram-positive bacteria [4]. Two bacterial 
resistance genes (ble genes), one from the 
transposon Tn5 and the other from the 
staphylococcal plasmid pUBll0 have been recently 
characterized [4-61. We have cloned and se- 
quenced a third gene designated Sh ble from the 
chromosomal DNA of tallysomycin-producing ac- 
tinomycetes (Drocourt, D., Gatignol, A., Calmels, 
T. and Tiraby, G., submitted). The proteins en- 
coded by the three genes are highly homologous 
and hence probably participate in the same 
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biochemical reaction. The Tn5 and Sh ble 
resistance genes have been exploited as dominant 
markers which can be selected with phleomycin in 
yeasts [7,8], fungi [9], plant cells [lo] and animal 
cells (Mulsant, P., Gatignol, A., Dalens, M. and 
Tiraby, G., submitted). The mechanisms of 
plasmid-determined resistance have been studied 
for numerous antimicrobial drugs [11,12] and 
recently reviewed [13] but until now the 
biochemical basis of the bleomycin resistance has 
not been elucidated. The ease with which the pro- 
tein of the Sh gene can be isolated in a purified 
form from a recombinant E. coli strain allowed us 
to investigate this question. In vitro assays 
demonstrated that the Sh protein prevents rever- 
sibly the action of bleomycin on DNA. The natural 
fluorescence of the Sh protein being quenched by 
the addition of bleomycin provides direct ex- 
perimental evidence that this protein could be a 
bleomycin-binding protein exerting its resistance 
activity by forming a complex with the antibiotic. 
2. MATERIALS AND METHODS 
2.1. Isolation of the Sh protein 
E. co/i cells of DH5 PIN-III-ompA2 [14] and DHS pUT50 
were grown in a 1 1 fermenter in LB medium. The pH was kept 
constant a 7 by automatic addition of 1 N potassium hydrox- 
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ide. After 14 h incubation at 37”C, 2 mM IPTG was added and 
growth was allowed for an additional 4 h. The cultures were 
centrifuged and periplasmic proteins extracted by osmotic 
shock [15]. Proteins collected in water were brought to 20 mM 
Tris-HCl, pH 6.7, and injected on a Q-Sepharose fast flow col- 
umn (Pharmacia) previously equilibrated with the same buffer. 
The resin was abundantly washed and the elution of fixed pro- 
teins was performed by sequential steps of increased NaCl con- 
centration in the same buffer. The column effluent was 
monitored at 280 nm and the UV absorbance vs time was 
recorded. Three fractions of both extracts were collected at 
0.3 M, 0.7 M and 1 M NaCl and analysed for a protective ef- 
fect on DNA treated with BLM as indicated in the legend of 
fig.2. Proteins of fraction II of the DHS pUTSO extract were 
precipitated by 2 vols of acetone at -20°C for 2 h and 
resuspended in 10 mM Tris-HCI, pH 7.5. The protein concen- 
tration of the purified protein was determined as described by 
Vernon et al. [16]. 
2.2. Bleomycin-mediated strand scission of DNA 
Reaction mixtures (20~1 total volume) contained 10 mM 
Tris-HCI buffer, pH 7.5. The Sh protein and BLM (1 gM final 
concentration) (BLM, Roger Bellon, France) were added se- 
quentially. The mixture was maintained for 5 min at 25°C and 
0.2 pg of DNA was added followed by 100 PM FeS04 from a 
freshly prepared solution and 1 mM dithiothreitol. The reaction 
was stopped by EDTA (40 mM) after 5 min incubation at 25°C. 
Following each reaction, 4 ~1 of a loading solution (Ficoll 15%, 
Bromophenol blue 0.25%) was added and the resulting solution 
was applied to a 0.8% agarose gel. After electrophoresis, the gel 
was stained with ethidium bromide, visualized and 
photographed. 
When specified, heat treatment was carried out by placing the 
Eppendorf tube containing the reaction mixtures prior to the 
addition of DNA for 1 h in a boiling water bath. Protease treat- 
ment was carried out by addition of 200 /g/ml of proteinase K 
and incubation at 45°C for 90 min. 
3. RESULTS AND DISCUSSION 
From the DNA of the tallysomycin-producer 
strain of Streptoalloteichus hindustanus ATCC 
31158, we recently cloned a gene (Sh) that confers 
high bleomycin-type antibiotic resistance in E. coli 
(Drocourt, D., Gatignol, A., Calmels, T. and 
Tiraby, G., submitted). The Sh structural gene has 
been cloned on PIN-III-ompA2, an E. coli induci- 
ble secretion vector [14], to give the plasmid 
pUTSO (not shown). Polyacrylamide gel elec- 
trophoresis of periplasmic proteins from the DH5 
strain revealed an additional intense band of the 
expected 14 kDa size protein only in extracts of 
cells harboring the pUTSO plasmid (not shown). 
The separation of the different protein com- 
ponents of periplasmic extracts was performed by 
fast liquid protein chromatography (FPLC). 
Because the Sh protein has a very low theoretical 
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isoelectric point (pl = 3.78), the extracts were sub- 
mitted to an anion-exchange column. As expected, 
a well resolved major peak present only in extracts 
from the bleomycin-resistant cells was eluted in a 
buffer with 0.7 M NaCl (fraction II) (fig.1). SDS- 
PAGE of the collected fraction II revealed a uni- 
que band at he expected position for the Sh pro- 
tein. The desalting and the concentration of the 
protein from this fraction were assured by acetone 
precipitation, a rather drastic procedure to which 
the Sh protein proved to be insensitive. The 
resuspended material was used to investigate the 
protective effect of the Sh protein toward the in 
vitro DNA-cleaving action of the bleomycin in the 
presence of ferrous ions. The results of these ex- 
periments are presented in fig..2. 
Bleomycin (BLM) at concentrations as low as 
1 PM completely degrades 0.2 pg of chromosomal, 
linear or covalently closed circle (CCC) DNA (and 
is itself inactivated) in 5 min at 25°C in a standard 
20 ~1 reaction mixture as revealed by agarose gel 
electrophoresis (fig.2A, lanes 4-6). The Sh protein 
added prior to BLM at concentrations of 6 PM or 
higher leads to a complete protection of the DNA 
(fig.2A, lanes 10-12) while at 3 PM protection is 
only partial (fig.2A, lanes 7-9). These results 
clearly indicate that the Sh protein prevents BLM- 
induced DNA breakage in vitro. Indeed when the 
amount of protein was not sufficient, the DNA 
was partially cleaved, even when the incubation 
time of the Sh protein with BLM was prolonged 
(2 h) or performed at 37°C (not shown). A lack of 
a necessary co-factor could explain the time- 
independence of the reaction. We were unable to 
find co-enzymes or ions that could activate the 
reaction to render it time-dependent. This 
hypothesis cannot be completely excluded, 
although results of experiments which follow in- 
dicate that the interaction Sh protein-bleomycin is 
not enzymatic. 
The Sh protein is a very stable polypeptide. It 
can however be inactivated by boiling for 1 h or by 
proteinase K (2OOpg/ml) treatment at 45°C for 
90 min (fig.2B, lanes 6,7). Under the same heat or 
protease treatment, BLM retains its full DNA- 
breaking potency (fig.%B, lanes 2,3). When the 
mixture Sh protein-BLM is treated under the same 
conditions, BLM recovers the ability to degrade 
the DNA (fig.ZB, lanes 9,lO). The reversibility of 
the inactivating effect implies that no enzymatic 
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Fig. 1. Chromatographic profile on a Q-Sepharose fast flow anion-exchange column of periplasmic extracts from E. coli cells harboring 
two different plasmids. Dashed line, DH5 PIN-III-ompA2; solid line, DH5 pUTSO. 
A 1 2 3 4 5 6 7 8 9101112 B 12 3 4 5 6 78 9 10 
Fig.2. Agarose gel electrophoresis of plasmid and chromosomal DNA treated with BLM alone or in combination with the Sh protein. 
(A) Inhibition of the BLM-mediated DNA breakage by the Sh protein. Lanes: l-3, DNA alone; 4-6, BLM + DNA; 7-9, Sh protein 
(3 PM) and BLM + DNA; 10-12, Sh protein (6 ,uM) and BLM + DNA. DNAs were from pBR322 (lanes 1,4,7,lO), pBR322 linearized 
by BumHI (lanes 2,5,8,11) and calf thymus DNA (lanes 3,6,9,12). (B) Restoration of the DNA breakage activity of the BLM combined 
with the Sh protein by a heat or protease treatment. Lanes: 1, control; ,2, BLM; 3, heat-treated BLM; 4, protease-treated BLM; 5 and 
8, BLM + Sh protein; 6, BLM + heat-treated Sh protein; 7, BLM + protease-treated Sh protein; 9, heat-treated BLM-Sh protein; 
10, protease-treated BLM-Sh protein. pBR322 DNA. 
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modification of the antibiotic molecule has been 
brought about by the Sh protein and suggests that 
the protein may exert its inhibitory effect by direct 
complex formation with BLM. 
To determine whether this is the case we have 
taken advantage of the strong fluorescence emis- 
sion with a maximum at 350 nm observed when the 
Sh protein is excited at 280 nm in aqueous solu- 
tions. This is probably due to the 5 tryptophan 
residues of the molecule. The fluorescence of the 
Sh protein in solution is progressively quenched by 
addition of increasing concentrations of metal-free 
BLM or BLM-Fe(I1) even after correction of the 
inner filter effect. When the reciprocal of the 
measured decrease of the fluorescence intensity is 
plotted versus the reciprocal of added BLM con- 
centrations, a straight line is obtained (with a 
regression coefficient always greater than 0.99) 
from which a half-saturating concentration (Kr/z) 
is calculated (fig.3). At low ionic strength (no 
NaCl), an identical complex presenting a K1/2 of 
55 nM (f 10) for a concentration of 400 nM Sh 
protein is observed both with metal-free BLM and 
BLM-Fe(I1). When the ionic strength is increased 
to 100 mM NaCl, metal-free BLM no longer 
decreases the fluorescence. Fluorescence quen- 
ching is, however, still observed with BLM-Fe(I1). 
In contrast to the results at low ionic strength, the 
double reciprocal plot exhibits a biphasic 
character. At low concentrations of BLM-Fe(H), 
the K1/2 is found at 50 nM ( f 10) for 400 nM pro- 
tein. At concentrations of the antibiotic equal or 
higher than that of the protein a K1/2 of 220 (& 70) 
nM is obtained. The large error associated with 
this value is due to the fact that BLM itself exhibits 
low fluorescence which can possibly be quenched 
by the protein. A half-saturating concentration of 
200 nM BLM-Fe(I1) for 400 nM protein is best in- 
terpreted by considering that one BLM molecule 
interacts with one protein molecule at 
physiological ionic strength. 
From these data it appears that the Sh protein is 
a BLM-binding protein which displays two types 
of interactions. One is purely electrostatic between 
the basic antibiotic and the acidic protein at low 
BLM concentrations. The other involves the for- 
mation, with a high affinity, of a complex between 
the binding protein and the BLM in a chelated 
form with Fe(I1) in a one to one ratio. Because of 
the specificity of this complex, it is likely that the 
binding takes place on the part of the molecule that 
chelates metal ions (the reactive site) rather than on 
the bithiazole moiety (DNA-binding site). Ex- 
periments with other chelated forms of BLM are in 
progress and should clarify this point. Studies 





Fig.3. Lineweaver-Burk representation of the reciprocals of fluorescence decrease intensities (AF) versus bleomjrcin concentrations. 
BLM or BLM-Fe(B) (up to 1.5 PM) was added to 2 ml of Sh protein (0.4 PM) in 1 mM Tris-HCI, pH 7.5. Experiments were carried 
out with a JY3 Jobin & Yvon spectrofluorimeter, h excitation = 280 nm, X emission = 350 nm, slit width at excitation = 10 nm, slit 
width at emission = 10 nm. BLM (M ) and BLM-Fe(B) (M) with the protein at low ionic strength, BLM-Fe(B) with the 
protein in 100 mM NaCl (s). 
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and 02 combine with BLM to form activated BLM 
which upon interaction with DNA produces two 
types of monomeric products, free base and base 
propenal [ 17,181. The manner by which a BLM- 
binding protein coded by the Sh gene and very like- 
ly by the Tn5 and the pUBll0 ble genes interferes 
with the activation of the BLM remains to be 
determined. 
The observation that in procaryotic and 
eucaryotic cells resistance levels to BLM or 
phleomycin are proportionately correlated with ex- 
pected expression levels of the Tn5 and the Sh 
gene, even at high levels (unpublished), is better 
understood in the light of the discovered 
stoichiometric relationship between the bfe protein 
and the drug. BLM has never been used as an an- 
timicrobial antibiotic and thereby, the occurrence 
of bleomycin-resistant pathogenic bacteria cannot 
be accounted for by the selective pressure exerted 
by this drug. The Sh ble gene cloned from an ac- 
tinomycete producer of a bleomycin-type an- 
tibiotic presumably participates in the self 
resistance of producing cells to the antibiotic and 
consequently one can assume that the bleomycin- 
binding effect described here is the primary func- 
tion of the bfe genes. Nevertheless, it still remains 
possible that the ble proteins display some other 
unrelated properties in a similar way to the 
chloramphenicol acetyltransferase of the only type 
I which enzymatically inactivates chloramphenicol 
and also sequesters fusidic acid and crystal violet 
by binding to these hydrophobic compounds [ 191. 
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